comparemela.com

Latest Breaking News On - Antonio breast cancer - Page 8 : comparemela.com

Why Is Cancer Focused Intensity Therapeutics Stock Trading Over 100% Today?

Intensity Therapeutics Inc INTS announced that safety, tolerability, efficacy, and immune activation data from its Phase 2 INVINCIBLE trial of INT230-6 in…

San antonioUnited statesIntensity therapeutics incAntonio breast cancerReaking news

Avelumab Improves PFS in HER2+ Metastatic Breast Cancer

Adding avelumab to vinorelbine and trastuzumab improved progression-free survival in a phase 3 trial of patients with HER2+ metastatic breast cancer. Adding avelumab to vinorelbine and trastuzumab improved progression-free survival in a phase 3 trial of patients with HER2+ metastatic breast cancer.

San antonioUnited statesAntonio breast cancer

HER2 Status May Influence Time to Next Treatment Post-Enhertu

Findings were presented at the 2023 San Antonio Breast Cancer Symposium from a study investigating real-world patients who received Enhertu for advanced breast cancer.

San antonioUnited statesPaolo tarantinoDuke cancer centerDana farber cancer instituteAntonio breast cancerDuke cancerBreast cancer

Jazz presents encouraging Phase 2 data for breast cancer treatment (JAZZ)

Jazz presents encouraging Phase 2 data for breast cancer treatment (JAZZ)
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

San antonioUnited statesJazz pharmaceuticalsAntonio breast cancer

SIM0270 Demonstrates Early Antitumor Activity in ER+/HER2– Advanced/Metastatic Breast Cancer

The brain-penetrant oral selective estrogen receptor degrader SIM0270 exhibited a favorable safety profile and early signals of antitumor activity in patients with estrogen receptor-positive, HER2-negative locally advanced or metastatic breast cancer, including those with ESR1 mutations.

Jian zhangSan antonioUnited statesFudan university shanghai cancer centerAntonio breast cancerResponse assessmentNeuro oncology brain metastasesSan antonio breast cancer symposiumBreast cancer

vimarsana © 2020. All Rights Reserved.